| Name | 4-[4-(2-aminopropan-2-yl)phenyl]-2-[4-(2-morpholin-4-ylethyl)anilino]pyrimidine-5-carbonitrile |
|---|---|
| Synonyms | unii-95rgx89oqd |
| Description | JNJ 17029259 is an orally active and selective VEGF-R2 kinase inhibitor. JNJ 17029259 inhibits VEGF-mediated signal transduction. JNJ 17029259 has anti-angiogenic activity[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H30N6O |
|---|---|
| Molecular Weight | 442.56 |
| Exact Mass | 442.24800 |
| PSA | 100.09000 |
| LogP | 4.53858 |